PET/MRI in the Diagnosis of Chronic Pain
Study Description
“PET/MRI in the Diagnosis of Chronic Pain”
Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using [18F]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of [18F]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - [18F]FTC-146
Adult participants will be injected with 5-10 mCi of [18F]FTC-146 and undergo a PET/MRI scan.
Additional Information
Official Study Title
Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain
Clinical Trial ID
NCT03556137
ParticipAid ID
zbqwpe
